This study aimed to compare the effects of true and sham acupuncture in relieving symptoms of irritable bowel syndrome (IBS).
INTRODUCTION
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by chronic or recurrent abdominal pain or discomfort, usually in the lower abdomen, which is associated with disturbed bowel function and feelings of abdominal distention and bloating (1) , which are o en relieved by defecation. An estimated 10 -15 % of adults in North America su er from IBS (2) , and it is associated with a signi cant reduction in health-related quality of life (3) . IBS is one of the most common reasons for work and school absenteeism (4) . Estimates of annual direct and indirect costs associated with IBS exceed 41 billion dollars in major industrial countries (5) .
e pathophysiology of IBS includes alterations in intestinal motility, visceral hypersensitivity, and abnormalities in processing visceral information. Until recently, most therapies for IBS have been directed at a speci c intestinal symptom (e.g., diarrhea, constipation, or abdominal pain) and have not been e ective in treating other symptoms associated with IBS. Although more recent therapies have shown promise, treatment options for IBS remain limited. erefore, it is not surprising that many patients with IBS have turned to complementary and alternative medicine (CAM) (6) , such as acupuncture. In one survey, approximately one-half of the patients with IBS reported using CAM (7) .
Acupuncture, an ancient traditional Chinese medical practice, is becoming more widely accepted and used in Western society (8) . Traditional Chinese medicine is based on a theory of energy or life force ( " qi " ) that runs through the body in channels known as meridians. Qi is essential to health, and disruptions of this ow, which are believed to contribute to symptoms and diseases, can be corrected at identi able anatomical locations ( " acupoints " ) using acupuncture. In IBS, acupuncture is
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believed to alter visceral sensation and motility by stimulating the somatic nervous system and the vagus nerve (9 -11) .
A 2006 Cochrane Database article reviewed six randomized trials using acupuncture in IBS (12) . e studies were generally of poor quality, included relatively small numbers of patients, and di ered signi cantly in the acupuncture method used. Limitations notwithstanding, this review found inconclusive evidence as to whether acupuncture is superior to sham acupuncture in IBS. Subsequently, Schneider et al. (13) published the results of a well-conducted study in which 43 IBS patients were randomized to acupuncture or sham acupuncture. ere was no signi cant di erence between the response rates in patients receiving acupuncture and those receiving sham acupuncture on a speci c quality-of-life measurement for functional bowel digestive disorders (14) , although patients in both groups improved signi cantly compared with baseline.
Our study comparing acupuncture with sham acupuncture was nested within a larger study examining the impact of the patient -practitioner interaction in IBS patients. In this larger study, which served as the run-in period for our study, participants were randomized to 3 weeks of (i) waitlist, (ii) sham acupuncture (twice a week) with a " limited " patient -practitioner encounter, or (iii) sham acupuncture (twice a week) with an " augmented " patient -practitioner encounter (i.e, a warm, friendly, and supportive patient -practitioner interaction). e results of this 3-week run-in study are reported elsewhere (15) . A er 3 weeks, participants receiving sham acupuncture were seamlessly and unknowingly re-randomized to continue for another 3 weeks on either acupuncture or sham acupuncture, with the same " limited " or " augmented " patient -practitioner encounter that they had received during the run-in phase of the trial. is second 3-week period comprises the acupuncture study reported in this study.
e aims of this trial were three-fold: (i) to determine if acupuncture provides greater relief from IBS symptoms than does sham acupuncture or waitlist control; (ii) to determine if eliminating patients who responded to sham acupuncture during the run-in period (i.e., patients who responded to sham acupuncture during the 3 weeks before randomization to acupuncture or sham acupuncture) widens the response-rate differences between acupuncture and sham acupuncture, perhaps to the point of statistical signi cance; and (iii) to determine if an " augmented " patient -practitioner interaction enhances the di erence in response rates between acupuncture and sham acupuncture.
METHODS

Study design
In the larger trial, 262 IBS patients were randomized to a 3-week run-in of either (i) waitlist (observation), (ii) sham acupuncture (2 sessions per week) with a " limited " patientpractitioner encounter, or (iii) sham acupuncture (2 sessions per week) with an " augmented " patient -practitioner encounter (i.e., a warm, friendly, and supportive patient -practitioner relationship). e larger study explored the e ects of placebo and patient -practitioner relationship in IBS. In this study, the " augmented " patient -practitioner encounter resulted in signi cant improvement in symptoms compared with that in the " limited " patient -practitioner encounter and in the " waitlist " group. ese results are reported elsewhere (15) .
For this study, at the end of week 3, all patients who had received sham acupuncture were re-randomized blindly to either acupuncture or continuation of sham acupuncture. is randomization was strati ed by the group assignment for the run-in period (augmented vs. limited) and by the post runin pain score ( < 30 vs. 30 on a 100-point visual analog scale). Patients continued with the same " limited " or " augmented " patient -practitioner interaction that they had received during the rst 3 weeks of the study. ey were unaware that only sham acupuncture had been administered during the run-in phase of this study and were similarly unaware of the existence of di erent patient -practitioner interactions. Patients who were initially in the waitlist control group continued on in this group. Figure 1 reviews the ow of patients through this study.
Treatment and study assessments were performed at the Beth Israel Deaconess Medical Center ' s General Clinical Research Center (GCRC). e Institutional Review Boards at the Beth Israel Deaconess Medical Center and Harvard Medical School approved the design, and all participants provided informed consent.
Participants
Participants were recruited from advertisements in media, iers, and through referrals from health professionals (16) . All participants were at least 18 years of age and met the Rome II criteria for IBS (17) . In addition, the diagnosis of IBS was con rmed by a board-certi ed gastroenterologist experienced in functional bowel disorders (A.J.L.), who also assessed for " warning symptoms " (unexplained weight loss, family history of colon cancer or in ammatory bowel disease, and rectal bleeding) (18, 19) . Participants were allowed to continue their IBS medications (e.g., ber, anti-spasmodics, and loperamide) as long as they had been on stable doses for at least 30 days before entering the study and agreed not to change medications or dosages during the trial. Patients were also asked not to make signi cant changes to their diet during the study. Patients were excluded if they had received acupuncture earlier, had undergone abdominal surgery (excluding cholecystectomy, appendectomy, hysterectomy, hernia repair), or were on narcotics or other pain medications (except non-steroidal anti-in ammatory drugs).
Interventions
Acupuncture . For this study, we used a manualized acupuncture protocol that combined a xed number of always-used acupuncture points and a menu of optional points that could be applied on the basis of the participant ' s Chinese medicine diagnosis (20) . is method allows for reproducibility and also exibility that many acupuncturists claim is critical for their practice. Accordingly, we chose six main xed acupoints and 11 optional points, which could be selected on the basis of a traditional Chinese acupuncture diagnosis of the individual patient by the acupuncturist. is regimen was developed by a consensus team of 8 senior acupuncturists, each with more than 15 years of experience. e xed points are very commonly used in IBS patients and included Conception Vessel 10, Stomach 25, Liver 3, Spleen 4, Pericardium 6, and Stomach 37. e optional points were Stomach 36 and Conception Vessel 4 (for the Chinese diagnosis of de ciency), Large Intestine 4 Liver 14, (for stagnant qi or energy), Stomach 40, Large Intestine 11 (for dampness), Stomach 27 (for cold), Conception Vessel 12 (for " retention of food " ), Gall Bladder 34 (for " damp heat " ), and Spleen 10 and Spleen 6 (for " blood stasis " ). Optional points could also replace the xed points if the acupuncturist considered them to be better. e optional points were discussed extensively by the acupuncture team and were selected on the basis of a shared understanding of Chinese medicine di erential diagnosis. If the acupuncturist felt strongly that a xed main point would be less desirable than an optimal point, they were allowed to replace a single xed point with an optional point. e sensation of grasping the energy ( " de qi " ) was obtained and the needles were le in place for 20 min (21) . Acupuncture treatment procedures were reviewed in regular team meetings.
Sham acupuncture . In this study, we used Streitberger needles (22) , a validated sham acupuncture device. is device has been shown to be indistinguishable from an actual acupuncture device; the " needle " does not pierce the skin but creates an illusion of doing so as it retracts into a hollow handle. Streitberger and true acupuncture needles were applied for an 
FUNCTIONAL GI DISORDERS
identical period of time. To avoid acupuncture pressure e ect, sham needles were placed over predetermined " non-acupuncture " points in the relative vicinity of the genuine points. Our team ' s precise method of using the sham needles is described elsewhere (23) .
During the placebo run-in phase, acupuncturists were instructed to select at least 5 and a maximum of 11 " non-acupuncture " points, as if they were actually performing genuine points. ey were also encouraged to slightly switch or adjust their point selection within the parameters of the study protocol from treatment to treatment (which is what would usually happen during regular practice). ese maneuvers were carried out so that patients who were randomized to genuine acupuncture would experience identical procedures in terms of number of needles and the attention of the acupuncturists when switched from placebo to genuine treatment. Of course, patients were entirely blind to the run-in phase of the trial and were unaware of any change from sham to genuine treatment in the protocol.
Practitioners . Four licensed acupuncturists, each with more than 2,000 h of professional training and more than 4 years of post-graduate experience, performed the acupuncture in this study. e method used for their training and supervision is described elsewhere (24) . Before the study began, all acupuncturists agreed that the therapeutic intervention they were going to perform was an e ective form of acupuncture.
Patient -practitioner interaction . Patients continued to receive the same patient -practitioner interaction (i.e., " limited " or " augmented " relationship) as they had received in the initial 3-week run-in trial. e details of the two scripted patient -practitioner interactions are reported elsewhere (15) . e random assignment of interactions across treatment arms allowed for a secondary comparison of acupuncture vs. sham acupuncture, each with two di erent styles of patient -practitioner interaction without compromising the outcome of our primary study objective.
Outcome measures
Primary outcome . e a priori primary endpoint of the study was the IBS Global Improvement Scale (IBS-GIS), which asked the participants, " Compared to the way you felt before you entered the study, have your IBS symptoms over the past 7 days been: (1) " Substantially Worse " , (2) " Moderately Worse, " (3) " Slightly Worse, " (4) " No Change, " (5) " Slightly Improved, " (6) " Moderately Improved, " or (7) " Substantially Improved " (25, 26) . A responder was de ned as a patient who answered either " moderately improved " or " substantially improved " to the foregoing question.
Secondary outcomes . Secondary outcomes measured in this study were IBS Adequate Relief (IBS-AR) (27, 28) , IBS Symptom Severity Scale (IBS-SSS) (29) , and IBS Quality of Life (IBS-QOL) Scale (30, 31) .
IBS-AR:
IBS-AR is a dichotomous single item that asks participants, " Over the past week have you had adequate relief of your IBS symptoms? " is type of outcome has been used extensively for assessing e cacy in IBS clinical trials (32, 33) and has been shown to correlate with improvement in individual IBS symptoms (27) . A responder was de ned as a patient who answered this question a rmatively.
IBS-SSS: e IBS-SSS contains ve questions that are rated on a 100-point visual analog scale, namely, the severity of abdominal pain, the frequency of abdominal pain, the severity of abdominal distention, dissatisfaction with bowel habits, and interference with the quality of life (29) . All ve components contribute to the score equally, yielding a theoretical range of 0 -500, with a higher score indicating a worse condition. Earlier studies have established that scores < 175 represent mild IBS symptoms, 175 -300 represent moderate severity, and 
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would decrease the response rate to sham acupuncture during the second 3-week phase of the trial and, therefore, widen the gap between acupuncture responders and sham acupuncture responders. However, contrary to our expectations, the gap between acupuncture responders and sham acupuncture responders narrowed for our primary outcome measure, the IBS-GIS (24 vs. scores >300 represent severe IBS (29) . A decrease of 50 points on the IBS-SSS has been shown to correlate with improvement in clinical symptoms. We therefore de ned patients with a decrease of 50 points on the IBS-SSS as responders in this study. IBS-QOL : e IBS-QOL is a 34-item measure assessing the degree to which IBS interferes with a patient ' s quality of life. Each item is rated on a 5-point Likert scale and all items are summed. e total score is then converted linearly to a 100-point scale, with higher scores indicating an improved quality of life (34) . In accordance with a study by Drossman et al. (30) , we de ned responders as patients whose IBS-QOL scores improved by 10 points from baseline.
Statistical analysis
For the primary endpoint, our sample size a orded 80 % power to detect a percentage point di erence in responder rates. Chi-square tests of independence were used to determine whether signi cant di erences existed between groups in the proportion of responders. In addition, where possible (i.e., for continuous measures), we also used parametric statistics ( t -tests and ANOVA (analysis of variance)) because of the potential for improved power. All analyses were intentto-treat, using the last-observation-carried-forward method. For clarity, in this study, we report only non-parametric analyses for dichotomous outcomes (i.e., responder vs. nonresponder), except in Table 1 . Parametric tests yielded similar results, except where noted in text. All tests were two-tailed with α set at 0.05.
RESULTS
Patient characteristics
Between December 2003 and February 2006, we screened 350 prospective participants and enrolled 262 into the study. Of the 262 potential patients, 32 patients (5 in the " augmented " arm, 17 in the " limited " arm, and 10 in the waitlist arm) discontinued the trial during the rst 3 weeks (i.e., before randomization between acupuncture and sham acupuncture). us, 230 patients entered into our study, as reported. Table 2 displays these patient characteristics by treatment group.
Acupuncture vs. sham acupuncture
On the IBS-GIS, 41 % of patients who received acupuncture were responders (i.e., " moderate " or " substantial " improvement in their IBS symptoms during the preceding week), whereas 32 % of patients who received sham acupuncture were responders ( P = 0.25). Although more acupuncture recipients were responders than were sham acupuncture recipients, the di erence was not statistically signi cant ( P = 0.25) ( Figure 2 ). Similar non-statistically signi cant di erences were seen in the responder rates for IBS-AR, IBS-QOL, and IBS-SSS ( Figure 2 ).
We had hoped that removing patients who responded to sham acupuncture during the 3-week run-in phase of the trial 
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Acupuncture and sham acupuncture vs. waitlist control
Patients receiving acupuncture or sham acupuncture were more likely to be responders on the IBS-GIS than were those in the waitlist control group (37 vs. 4 % , P < 0.001) ( Figure 2 ). Similarly, patients receiving acupuncture or sham acupuncture compared with those on the waitlist control were signicantly more likely to be responders on the IBS-AR (58 vs. 35 % , P < 0.001) and IBS-SSS (26 % vs. 14 % , P = 0.04). ere was a numerical but not a signi cant di erence for IBS-QOL (15 vs. 12 % , P = 0.49) between those receiving acupuncture or sham acupuncture and those in the waitlist control.
Effect of patient -practitioner interaction on response rates
For the IBS-GIS in both a limited and an augmented patientpractitioner interaction, acupuncture showed a slight, nonstatistically signi cant superiority when compared with sham acupuncture ( Table 1 ) . As the di erence in response rates between augmented acupuncture and augmented sham acupuncture and between limited acupuncture and limited sham acupuncture is similar, the interaction by which acupuncture is delivered does not appear to a ect its superiority over sham acupuncture. Similar results were seen for the secondary endpoints with the exception of the IBS-QOL in the " limited " acupuncture arm.
Adverse events ree adverse events were reported during the acupuncture vs. sham acupuncture phase of the study: (i) painful foot cramp a er treatment (sham acupuncture), (ii) nausea or hip pain (true acupuncture), and (iii) rib pain a er a fall (sham acupuncture). All of these events were considered to be unrelated to the study procedure.
DISCUSSION
Our study is the largest randomized controlled trial with acupuncture to be performed in IBS. Our results showed that acupuncture and sham acupuncture are not signi cantly di erent in improving the symptoms of IBS, although both treatments are signi cantly better than no treatment (i.e., waitlist). Eliminating responders in the run-in phase of the study, in which patients received only sham acupuncture,
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Acupuncture for IBS medicine diagnoses, on which acupuncture is usually based, was not used in this study (45) . Moreover, some might object to our manualized approach to acupuncture treatment and argue for either a fully standardized or a totally exible protocol. We feel that our manualized procedure is as close to actual clinical practice as allowed by reproducibility. It is debated in the acupuncture literature whether sham acupuncture, although indistinguishable from acupuncture, is indeed ine ective. e mechanism of acupuncture is unknown and sham acupuncture may be a less e ective form of acupuncture (46) and its mechanism may be di erent from that of acupuncture (47) . Finally, because our measures to assess e cacy were speci c to IBS symptoms, our study does not rule out the non-IBS bene ts of acupuncture.
In summary, although our study failed to show a statistically signi cant superiority of acupuncture over sham acupuncture in the treatment of IBS, patients receiving both acupuncture and sham acupuncture improved signi cantly compared with those in the waitlist control.
had no substantive e ect on the outcome. Finally, the context of the patient -practitioner interaction (i.e., a warm, friendly, and a supportive relationship ( " augmented " ), or a neutral ( " limited " ) relationship) also did not modify the difference in responder rates between acupuncture and sham acupuncture.
Our ndings are consistent with the majority of trials of acupuncture in IBS included in the recent Cochrane Database Review (12) and the subsequent study by Schneider et al. (13) from Germany. Similar to our trial, the German study found a numerically small superiority of improvement in patients receiving acupuncture compared with that in those receiving sham acupuncture. e German study included 43 patients and estimated the number of patients needed to adequately power such a study to be 566, if acupuncture had e cacy beyond placebo; we found this number to be ~ 970. Importantly, in contrast to the study by Schneider et al. (13) , which did not have a waitlist control (or standard of care) arm, our study found response rates in patients receiving acupuncture and sham acupuncture to be superior to that of patients in the waitlist control. is shows unequivocally that symptom improvement was not the result of natural history or regression to the mean. Our ndings are consistent with the results of recent large German acupuncture trials for other illnesses, such as chronic low back pain (35) , tension-type headache (36) , migraine (37, 38) , and osteoarthritis of the knee (39) , in which acupuncture and sham acupuncture were not different in e cacy, but both were superior to no treatment or standard of care. In April 2006, the German health authorities decided to reimburse for acupuncture for low back pain and osteoarthritis of the knee (but not for headache or other types of osteoarthritis) on the basis of the bene cial e ects over no treatment or standard of care and its potential cost savings (40 -42) .
We had hoped that removing patients who had responded to sham acupuncture during the 3-week run-in phase of the trial would decrease the response rate to sham acupuncture during the second 3-week phase of the trial and, therefore, widen the gap between acupuncture responders and sham acupuncture responders. However, our results do not show a widening of the gap. In fact, contrary to expectations, the di erence between acupuncture responders and sham acupuncture responders actually narrowed for our primary outcome measure (IBS-GIS) and for IBS-SSS. Our ndings support other studies that have also failed to nd increased e ciency in detecting intervention-placebo di erences with the removal of placebo responders during a run-in phase (43, 44) .
Our study had several limitations. First, six treatments of acupuncture over 3 weeks may have been insu cient to achieve the maximum e ect from acupuncture. Second, this study was nested in a larger study that was designed to evaluate the e ects of patient -practitioner interaction in IBS. us, a run-in phase occurred before randomization between acupuncture and sham acupuncture, which had a signi cant drop-out rate and thereby decreased the power of our study. ird, traditional Chinese
